MENINGITIS mortality declined markedly across three decades, but recent outbreaks show global progress remains severely off course. According to a comprehensive epidemiological analysis evaluating global burden data from 1990 to 2023, acute meningitis accounted for approximately 259,000 deaths and 2.54 million incident cases in 2023. Although worldwide mortality rates dropped by 63.5% since 1990, progress has slowed substantially in recent years, falling by only 25.4% after 2015. This current pace leaves international health initiatives well behind the World Health Organization targets to reduce bacterial meningitis deaths by 70% and incidence by 50% by 2030.
Vaccine-preventable bacteria continue to drive the highest clinical mortality worldwide. Streptococcus pneumoniae and Neisseria meningitidis remained the leading fatal etiologies, responsible for 41,400 and 34,400 deaths, respectively. Pediatric patients endure an excessive share of this severe burden, as children younger than five years accounted for more than one third of all global fatalities. In neonates, Group B streptococcus generated the highest mortality rates during the first week of life. Concurrently, non-polio enteroviruses emerged as the primary driver of overall meningitis incidence, causing 870,000 cases in 2023. Newly modeled fungal pathogens, specifically Candida species, represented over 92,000 cases, underscoring the expanding threat of healthcare-associated infections and antimicrobial resistance among hospitalized patients.
Modifiable risk factors significantly amplify clinical vulnerability across age groups. Low birthweight and short gestation represented the leading contributors to fatal outcomes, directly predisposing neonates to invasive central nervous system infection. Environmental exposures, particularly household air pollution from solid fuels and ambient particulate matter, also contributed to disease susceptibility. Geographically, the African meningitis belt continues to experience high endemic transmission and recurrent seasonal outbreaks, with Nigeria, Niger, and Chad reporting the highest mortality rates globally. For clinicians, these findings emphasize that overcoming diagnostic delays, reinforcing routine childhood immunization schedules, expanding maternal screening protocols, and practicing vigilant antimicrobial stewardship remain essential to prevent severe neurological sequelae and permanent patient disability.
Reference
Sirota SB et al. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurol. 2026;25(5):451-468.
Featured Image: H_Ko on Adobe Stock.
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.
